Literature DB >> 20448069

Drug coverage for transplantation turns into political football: big business trumps patients.

David J Cohen, Barbara Murphy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20448069     DOI: 10.2215/CJN.01630210

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  6 in total

Review 1.  IMPROVING LONG-TERM OUTCOMES IN KIDNEY TRANSPLANTATION: TOWARDS A NEW PARADIGM OF POST-TRANSPLANT CARE IN THE UNITED STATES.

Authors:  Robert S Gaston
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

2.  Cost-related immunosuppressive medication nonadherence among kidney transplant recipients.

Authors:  Roger W Evans; William H Applegate; David M Briscoe; David J Cohen; Christopher C Rorick; Barbara T Murphy; Joren C Madsen
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-16       Impact factor: 8.237

Review 3.  Future of Medicare immunosuppressive drug coverage for kidney transplant recipients in the United States.

Authors:  Bekir Tanriover; Patricia W Stone; Sumit Mohan; David J Cohen; Robert S Gaston
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-04       Impact factor: 8.237

4.  The Cost of Transplant Immunosuppressant Therapy: Is This Sustainable?

Authors:  Alexandra James; Roslyn B Mannon
Journal:  Curr Transplant Rep       Date:  2015-06-01

5.  Passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act-a Chance to Celebrate and Reflect.

Authors:  John S Gill; Richard N Formica; Barbara Murphy
Journal:  J Am Soc Nephrol       Date:  2021-03-02       Impact factor: 10.121

6.  Transplant coordinators' perceived impact of availability of multiple generic immunosuppression therapies on patients, workload, and posttransplant maintenance therapy.

Authors:  K Parker; E A Zagadailov; A S Bruno; A M Wiland
Journal:  J Transplant       Date:  2013-01-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.